Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JS005 Ib/II Trial in Moderate-to-Severe Plaque Psoriasis
CTR20202531Phase 2Completed
- Sponsor
- Shanghai Junshi Biosciences Co., Ltd.
- Start
- Dec 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of roconkibart in psoriasis, sponsored by Shanghai Junshi Biosciences Co., Ltd.. Started Dec 2020; status: completed.
02
Drugs
roconkibart
03
Conditions
psoriasis
Beyond the preview
Go deeper on CTR20202531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202531.